Navigation Links
Validant Names Michael Beatrice as New Company President
Date:5/2/2013

SAN FRANCISCO, May 2, 2013 /PRNewswire/ -- Today, Validant, a leading Quality and Regulatory services firm to global biotechnology, pharmaceutical, and medical device companies, named Michael Beatrice , PhD, as company President.

In this role, Mike will assume oversight of all existing client operations and lead the design and development of future service offerings.

"Mike will draw from his broad experience and strong leadership qualities to contribute significantly to Validant's current engagements.  In addition, his vision will direct Validant's next generation of products and services…" Brian Healy , CEO.

Prior to joining Validant, Mike spent the past thirteen years as Corporate Vice President, Abbott Quality and Regulatory, Abbott Laboratories.

Prior to that, he spent more than 20 years at the Food and Drug Administration (FDA), including three years as the Deputy Director of the Center for Biologics Evaluation and Research (CBER).

Beatrice holds a Bachelors of Science degree in pharmacy from the University of New Mexico, a Master of Science degree in pharmacy/biopharmaceutics from University of Oklahoma and a PhD in Pharmaceutics / Pharmaceutical Manufacturing from the University of Maryland.

About Validant

Validant is a leading Quality and Regulatory services firm to the regulated life sciences manufacturing industry.  With a proven track record of hundreds of successful client engagements with Fortune 500 companies, including 7 of the top 10 biotechnology, pharmaceutical and medical device companies, Validant has differentiated itself as the premier partner for clients looking to leverage the largest network of quality, regulatory, manufacturing and engineering professionals in the country.  More information is available at www.validant.com.


'/>"/>
SOURCE Validant
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Exosome Diagnostics Names Kapil Dhingra Chairman of the Board of Directors
2. TNI BioTech Names Terry Lierman of Summit Global Ventures as a Strategic Advisor
3. BIOCOM Names Rick Fultz Vice President of Business Development
4. Bayer CropScience Names Jeremy Jack 2013 Young Sustainable Farmer at Ag Issues Forum
5. Elsevier Names Dr. Jim Nolin Editor-in-Chief of Order Set Solution
6. Quantason Names Dr. Ellen B. Mendelson, Medical Director
7. Nano Mask Names Dr. Hassan Bennani to Board of Directors
8. SPIE Names 69 New Fellows of the Society in 2013
9. PathoGenetix Names Ann Merrifield as Chief Executive Officer and Prepares to Launch Unique Bacterial Identification Technology
10. AtheroNova Names New Director
11. FierceBiotech Names Enanta Pharmaceuticals, Inc. a Fierce 15 Winner
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/26/2019)... ... , ... Sparks Marketing Group, Inc. (Sparks) announced ... healthcare-specific marketing firm, to strengthen the agency’s growing focus on the healthcare vertical ... in pharma, bio-therapeutics, medical device and healthcare technologies currently account for a large ...
(Date:10/22/2019)... ... 2019 , ... Catalent, a global leader in clinical supply services, today announced ... participate in a panel session titled “Cell and Gene Therapy Logistics” at the upcoming ... Chicago, on Oct. 28-30, 2019. , The panel session, on Wednesday, Oct. 30 at ...
(Date:10/22/2019)... ... October 22, 2019 , ... ... that its lead program, DBI-001, met its primary safety endpoints, with no application ... 2a clinical trial for the treatment of interdigital tinea pedis (athlete’s foot). Additionally, ...
(Date:10/17/2019)... HAVEN, Conn. (PRWEB) , ... October 16, 2019 ... ... company that provides personalized, easy-to-understand, web-based genetic counseling information, has published a new ... a five year period and provides guidance as to how patients and medical ...
Breaking Biology Technology:
(Date:11/19/2019)... ... November 19, 2019 , ... The inaugural Cell & Gene Therapy Day takes ... The one-day event will be chaired by Dr Aiman Shalabi, VP R&D, Cell and ... , “We are witnessing significant innovation in cell and gene therapies, and we are ...
(Date:11/14/2019)... , ... November 13, 2019 , ... Personalized Stem ... first patients in an FDA approved clinical trial for stem cell treatment of ... formation of the company as a subsidiary of VetStem Biopharma. , In July of ...
(Date:11/12/2019)... (PRWEB) , ... November 12, 2019 , ... ... Cross-Channel Spend Optimizer that improves digital advertising performance up to 25% and reduces ... Advertising, Cross-Channel Spend Optimizer uses advanced multi-touch attribution (MTA) to predict best advertising ...
Breaking Biology News(10 mins):